<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments for Cardio Flow, Inc.	</title>
	<atom:link href="https://cardioflow.net/comments/feed/" rel="self" type="application/rss+xml" />
	<link>https://cardioflow.net/</link>
	<description>A new orbital atherectomy technology</description>
	<lastBuildDate>Tue, 31 Oct 2023 02:44:47 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>
		Comment on FreedomFlow Orbital Atherectomy Platform Receives FDA 510(k) Clearance to Treat Peripheral Artery Disease by Cardio Flow receives US FDA clearance for FreedomFlow platform - MetaMedical™ Solutions Inc		</title>
		<link>https://cardioflow.net/freedomflow-orbital-atherectomy-platform-receives-fda-510k-clearance-to-treat-peripheral-artery-disease/#comment-14</link>

		<dc:creator><![CDATA[Cardio Flow receives US FDA clearance for FreedomFlow platform - MetaMedical™ Solutions Inc]]></dc:creator>
		<pubDate>Thu, 19 Oct 2023 08:39:31 +0000</pubDate>
		<guid isPermaLink="false">https://cardioflow.net/?p=12519#comment-14</guid>

					<description><![CDATA[[&#8230;] Flow has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its FreedomFlow Orbital Atherectomy Peripheral [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] Flow has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its FreedomFlow Orbital Atherectomy Peripheral [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
